DE2545329A1 - 1-amid-alkyl-4-sulfonyl-piperazin-derivate - Google Patents

1-amid-alkyl-4-sulfonyl-piperazin-derivate

Info

Publication number
DE2545329A1
DE2545329A1 DE19752545329 DE2545329A DE2545329A1 DE 2545329 A1 DE2545329 A1 DE 2545329A1 DE 19752545329 DE19752545329 DE 19752545329 DE 2545329 A DE2545329 A DE 2545329A DE 2545329 A1 DE2545329 A1 DE 2545329A1
Authority
DE
Germany
Prior art keywords
alkyl
sulfonyl
amide
original
stage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19752545329
Other languages
German (de)
English (en)
Inventor
Lozano Juan Berjejo
Alcaide Garcia
Conde Ruiz Juan Ramon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Liade SA
Original Assignee
Laboratorios Liade SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Liade SA filed Critical Laboratorios Liade SA
Publication of DE2545329A1 publication Critical patent/DE2545329A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DE19752545329 1974-11-27 1975-10-09 1-amid-alkyl-4-sulfonyl-piperazin-derivate Pending DE2545329A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES432334A ES432334A1 (es) 1974-11-27 1974-11-27 Procedimiento de obtencion de derivados 1-amido alquil-4- sulfonil-piperazina.

Publications (1)

Publication Number Publication Date
DE2545329A1 true DE2545329A1 (de) 1976-08-12

Family

ID=8468076

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752545329 Pending DE2545329A1 (de) 1974-11-27 1975-10-09 1-amid-alkyl-4-sulfonyl-piperazin-derivate

Country Status (5)

Country Link
JP (1) JPS5165778A (es)
CH (1) CH605833A5 (es)
DE (1) DE2545329A1 (es)
ES (1) ES432334A1 (es)
FR (1) FR2292477A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001058436A1 (en) * 2000-02-11 2001-08-16 Genomine, Inc. Antagonists for nicotinic acetylcholine receptor, which are containing borneol or camphor as an active ingredient

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56157809U (es) * 1980-04-24 1981-11-25
US5648352A (en) * 1991-09-13 1997-07-15 Merck & Co., Inc. Piperazinylcamphorsulfonyl oxytocin antagonists
EP0533242A3 (en) * 1991-09-16 1993-09-15 Merck & Co. Inc. Substituted derivatives of piperazinylcamphorsulfonyl oxytocin antagonists
EP0533241A3 (en) * 1991-09-16 1993-09-29 Merck & Co. Inc. Substituted alkyl derivatives of piperazinylcamphorsulfonyl oxytocin antagonists
EP0533240A3 (en) * 1991-09-16 1993-09-29 Merck & Co. Inc. Substituted amine derivatives of piperazinylcamphorsulfonyl oxytocin antagonists
ATE216580T1 (de) * 1993-07-16 2002-05-15 Merck & Co Inc Benzoxazinon- und benzopyrimidinon- piperidinyl- verbindungen als tokolytische oxytocin-rezeptor- antagonisten
CA2166974A1 (en) * 1993-07-16 1995-01-26 Mark G. Bock Substituted amide derivatives of piperizinylcamphor sulfonyl and carbonyl oxytocin antagonists
US5464788A (en) * 1994-03-24 1995-11-07 Merck & Co., Inc. Tocolytic oxytocin receptor antagonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES374515A1 (es) * 1969-12-12 1972-01-01 Liade Sa Lab Procedimiento de obtencion de nuevos compuestos con accio- nes cardiovasculares.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001058436A1 (en) * 2000-02-11 2001-08-16 Genomine, Inc. Antagonists for nicotinic acetylcholine receptor, which are containing borneol or camphor as an active ingredient

Also Published As

Publication number Publication date
FR2292477B1 (es) 1979-09-14
JPS541317B2 (es) 1979-01-23
CH605833A5 (es) 1978-10-13
JPS5165778A (en) 1976-06-07
ES432334A1 (es) 1976-11-01
FR2292477A1 (fr) 1976-06-25

Similar Documents

Publication Publication Date Title
DE69531624T2 (de) Verfahren zur herstellung von levobupivacaine und analoge
DE2545329A1 (de) 1-amid-alkyl-4-sulfonyl-piperazin-derivate
DE1906527C3 (de) Thioninderivate, Verfahren zu deren Herstellung und pharmazeutische Präparate, welche diese enthalten
DE3016752A1 (de) Verfahren zur herstellung von 2-isopropylaminopyrimidinhydroxy-derivaten
DE1593728A1 (de) Verfahren zur Herstellung von substituierten Amidinen
DE2538095A1 (de) Neue organische verbindungen, ihre herstellung und verwendung
DE2600325A1 (de) Butazonderivate, verfahren zu deren herstellung und sie enthaltende arzneimittel
DE1670814A1 (de) Verfahren zur Herstellung von Enaminen
DE1468135A1 (de) Organische Amine und Verfahren zu deren Herstellung
DE2417866A1 (de) Verfahren zur herstellung von 2,5disubstituierten benzamiden
DE2757057A1 (de) Daunomycinderivate, verfahren zu ihrer herstellung und ihre verwendung
DE1693032B1 (de) Verfahren zur Herstellung von 1,2-disubstituierten Adamantanverbindungen
DE2166270A1 (de) Aminoaethansulfonylderivate
DE1595875C (de) Phenothiazine und Verfahren zu deren Herstellung
DE944854C (de) Verfahren zur Herstellung von halogenierten 8-Oxychinolinverbindungen
DE2623077A1 (de) Verfahren zur herstellung von n-(1- ethyl-2-pyrrolidinylmethyl)-2-methoxy-5- sulfamoylbenzamid
DE1197887B (de) Verfahren zur Herstellung von 3-Trifluormethylphenoxazinderivaten
DE1620747A1 (de) Verfahren zum Herstellen von Thiaminderivaten
DE2150279A1 (de) Blutzuckersenkende sulfamoylpyrimidine mit asymmetrischem kohlenstoffatom
DE2021962B2 (de) Blutzuckersenkende Sulfamoylpyrimidine mit asymmetrischem Kohlenstoffatom
DE2545330A1 (de) Sulfonylpiperazine
DE878655C (de) Verfahren zur Herstellung von antihistaminischen Substanzen
CH626870A5 (es)
DE1695549A1 (de) Aziridinderivate und Verfahren zu ihrer Umwandlung in Phenylalanine
AT286495B (de) Verfahren zur Herstellung von neuen Estern des α-Amino-benzylpenicillins

Legal Events

Date Code Title Description
OHW Rejection